scispace - formally typeset
N

Nicola Pusterla

Researcher at University of California, Davis

Publications -  342
Citations -  7015

Nicola Pusterla is an academic researcher from University of California, Davis. The author has contributed to research in topics: Lawsonia intracellularis & Ehrlichia. The author has an hindex of 41, co-authored 313 publications receiving 6056 citations. Previous affiliations of Nicola Pusterla include University of Kentucky & University of Southern California.

Papers
More filters
Journal ArticleDOI

Ehrlichioses in Humans: Epidemiology, Clinical Presentation, Diagnosis, and Treatment

TL;DR: Once an ehrlichiosis is suspected on historical and clinical grounds, doxycycline treatment should be initiated concurrently with attempts at etiologic confirmation using laboratory methods such as blood smear examination, polymerase chain reaction, culture, and serologic tests.
Journal ArticleDOI

Equine Herpesvirus‐1 Consensus Statement

TL;DR: This consensus statement draws together current knowledge in the areas of pathogenesis, strain variation, epidemiology, diagnostic testing, vaccination, outbreak prevention and control, and treatment of herpesvirus-1.
Journal ArticleDOI

Quantitative Real-Time PCR for Detection of Members of the Ehrlichia phagocytophila Genogroup in Host Animals and Ixodes ricinus Ticks

TL;DR: The prevalence of infected free-living ticks, which were collected from areas where bovine ehrlichiosis is endemic and from regions with sporadic occurrences of granulocytic ehrliciosis in dogs and horses, was identical as determined by nested PCR and TaqMan PCR.
Journal ArticleDOI

Serologic Cross-Reactivity between Anaplasma marginale and Anaplasma phagocytophilum

TL;DR: It is demonstrated that cattle, sheep and horses experimentally infected with A. phagocytophilum not only develop antibodies to A.phagocyTophilums, but also to a competitive enzyme-linked immunosorbent assay of A. marginale (detected by immunofluorescent-antibody assay).
Journal ArticleDOI

Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995-2004).

TL;DR: The value of intratumoral chemotherapy with cisplatin for treatment of cutaneous tumors in equidae was confirmed and the results cannot be extrapolated to other formulations of cisPlatin or other protocols that might be used.